HAC (Russian)
RSCI (Russian)
EBSCO
DOI (USA)
Ulrichsweb (Ulrich’s Periodicals Directory)
Scientific Indexing Services

Psychoautonomic status and silent myocardial ischemia in premenopause in the presence of metabolically healthy obesity

DOI: https://doi.org/10.29296/25877305-2019-04-15
Issue: 
4
Year: 
2019

M. Khabibulina, Candidate of Medical Sciences Ural State Medical University, Yekaterinburg

The examination of 194 women with metabolically healthy obesity (MHO) during the menopausal transition period (MTP) has established an association of silent myocardial ischemia (SMI) episodes with hypoestrogenemia, psychoautonomic disorders, and hypersympathicotonia, as well as that of SMI episodes in cardialgia with coronary spasm. It has been suggested that SMI with MHO in MTP can be considered as a silent variant of cardiac syndrome X and as an additional type IA variant of SMI in the classification proposed by P. Cohn (1993).

Keywords: 
cardiology
endocrinology
silent myocardial ischemia
metabolically healthy obesity
menopausal transition period



References: 
  1. Oganov R.G., Maslennikova G.Ja. Demograficheskie tendentsii v Rossijskoj Federatsii: vklad boleznej sistemy krovoobraschenija // Kardiovask. ter. i profilakt. – 2010; 11 (1): 5–10 [Oganov R.G., Maslennikova G.Ya. Demographic trends in the Russian Federation: the impact of cardiovascular disease // Cardiovascular Therapy and Prevention. – 2012; 11 (1): 5–10 (in Russ.)].
  2. Ford E., Capewell S. Proportion of the decline in cardiovascular mortality disease dueto prevention versus treatment: public health versus clinical care // Annu Rev. Public Health. – 2011; 21 (32): 5–22.
  3. Habibulina M.M. Vlijanie gipoestrogenemii na kachestvo zhizni zhenschin s arterial'noj gipertoniej v period premenpauzy // Kardiologija. – 2013; 53 (11): 45–8 [Khabibulina M.M. Effect of Hypoestrogenemia on Quality of Life of Premenopausal Women With Arterial Hypertension // Kardiologiya. – 2013; 53 (11): 45–8 (in Russ.)].
  4. Habibulina M.M. Kardiovaskuljarnyj risk pri estrogenodefitsite v doklimaktericheskih periodah. Rukovodstvo dlja vrachej / Ekaterinburg, 2014; 143 s. [Khabibulina M.M. Kardiovaskulyarnyi risk pri estrogenodefitsite v doklimaktericheskikh periodakh. Rukovodstvo dlya vrachei / Ekaterinburg, 2014; 143 r. (in Russ.)].
  5. Smetnik V.P. Lechenie klimaktericheskih rasstrojstv // Med. sovet. – 2007; 4: 38–43 [Smetnik V.P. Lechenie klimaktericheskikh rasstroistv // Med. sovet. – 2007; 4: 38–43 (in Russ.)].
  6. Habibulina M.M. Vlijanie trojnoj gipotenzivnoj terapii na remodelirovanie serdtsa, bezbolevuju ishemiju miokarda pri arterial'noj gipertenzii s estrogenodefitsitom v premenopauze // Vrach. – 2018; 29 (10): 32–6 [Khabibulina M. Impact of triple antihypertensive therapy on cardiac remodeling, silent myocardial ischemia in hypertension in premenopausal women with estrogen deficiency // Vrach. – 2018; 29 (10): 32–6 (in Russ.)]. https://doi.org/10.29296/25877305-2018-10-09.
  7. Sims E. Characterization of the syndromes of obesity. In: Brodoff BN, Bleicher SJ, editors. Diabetes Mellitus and Obesity / Baltimore: Williams and Wilkins, 1982; p. 219–26.
  8. Rey-Lopez J., de Rezende L., Pastor-Valero M. et al. The prevalence of metabolically healthy obesity: a systematic review and critical evaluation of the definitions used // Obes. Rev. – 2014; 15 (10): 781–90.
  9. Romantsova T.I., Ostrovskaja E.V. Metabolicheski zdorovoe ozhirenie: definitsii, protektivnye faktory, klinicheskaja znachimost' // Al'manah klinicheskoj meditsiny. – 2015; 13 (21): 75–86 [Romantsova T.I., Ostrovskaya E.V. Metabolically healthy obesity: definitions, protective factors, clinical relevance // Al'manakh klinicheskoi meditsiny. – 2015; 13 (21): 75–86 (in Russ.)].
  10. Robertson L., Aneni E., Maziak W. et al. Metabolically healthy obese phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality – a systematic review // BMC Public Health. – 2014; 14: 14.
  11. Biobank Standardisation and Harmonisation for Research Excellence in the European Union From 2010-12-01 to 2015-11-30, project 261433. – tsit. po: Romantsova T.I., Ostrovskaja E.V. Metabolicheski zdorovoe ozhirenie: definitsii, protektivnye faktory, klinicheskaja znachimost' // Al'manah klinicheskoj meditsiny. – 2015; 13 (21): 75–87.
  12. Rey-Lopez J., de Rezende L., Pastor-Valero M. et al. The prevalence of metabolically healthy obesity: a systematic review and critical evaluation of the definitions used // Obes. Rev. – 2014; 15 (10): 781–90.
  13. Muñoz-Garach A., Cornejo-Pareja I., Tinahones F. Does Metabolically Healthy Obesity Exist? // Nutrients. – 2016; 8 (6): E320. DOI: 10.3390/nu8060320.
  14. Habibulina M.M. Mezhgennye vzaimodejstvija v formirovanii u zhenschin bezbolevoj ishemii miokarda // Vrach. – 2015; 9: 44–6 [Khabibulina M. Intergenic interactions in the development of silent myocardial ischemia // Vrach. – 2015; 9: 44–6 (in Russ.)].
  15. Habibulina M.M., Smolentseva A.A. Terapija trevozhnyh rasstrojstv u zhenschin s arterial'noj gipertenziej v period premenopauzy na ambulatornom etape. V sb.: V s'ezd kardiologov Ural'skogo federal'nogo okruga (materialy s'ezda), 2011; s. 282–4 [Khabibulina M.M., Smolentseva A.A. Terapiya trevozhnykh rasstroistv u zhenshchin s arterial'noi gipertenziei v period premenopauzy na ambulatornom etape. V sb.: V s"ezd kardiologov Ural'skogo federal'nogo okruga (materialy s"ezda), 2011; s. 282–4 (in Russ.)].
  16. Sychev O.S. Ambulatornoe holterovskoe monitorirovanie EKG // Ukr. kardiol. zhurn. – 2005; 5: 11–36 [Sychev O.S. Ambulatornoe kholterovskoe monitorirovanie EKG // Ukr. kardiol. zhurn. – 2005; 5: 11–36 (in Russ.)].
  17. Habibulina M.M. Gemodinamicheskie pokazateli u zhenschin s gipoestrogenemiej pri metabolicheski zdorovom ozhirenii // Vrach. – 2018; 29 (1): 34–7 [Khabibulina M. Hemodynamic parameters in women with hypoestrogenemia with metabolically healthy obesity // Vrach. – 2018; 29 (1): 34–7 (in Russ.)].
  18. Habibulina M.M. Vyjavlenie bezbolevoj ishemii miokarda na ambulatornom etape u zhenschin s arterial'noj gipertenziej i kardialgiej v period premenopauzy // Ros. kardiol. zhurn. – 2011; 16 (6): 14–8 [Khabibulina M.M. Ambulatory diagnostics of painless myocardial ischemia in premenopausal women with arterial hypertension and cardialgia // Russian Journal of Cardiology. – 2011; 16 (6): 14–8 (in Russ.)]. https://doi.org/10.15829/1560-4071-2011-6-46-51.
  19. Eckel N., Li Y., Kuxhaus O. et al. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study // The Lancet Diabetes & Endocrinology. – 2018; DOI: 10.1016/S2213-8587(18)30137-2.